New Congress Prepares Lengthy Science Agenda

WASHINGTON—The 100th Congress has tried to set the tone of political debate in the country by moving quickly on several issues in its first few weeks. Its science panels have been equally quick to assemble their own agenda for the coming months. One group that is certain to vie for the spotlight is a new task force on technology policy that will encompass the effect of current practices on scientific R&D in the United States. The group, expected to be chaired by Rep. Buddy MacKay (D-Fla.),

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

One group that is certain to vie for the spotlight is a new task force on technology policy that will encompass the effect of current practices on scientific R&D in the United States.

The group, expected to be chaired by Rep. Buddy MacKay (D-Fla.), will perform its work under the auspices of the House Science, Space and Technology Committee. The new chairman of that committee, Rep. Robert Roe (DN.J.), considers the study a follow-up to a review of the nation's science policy conducted during the previous Congress by Donald Fuqua, a veteran Democrat who retired in December. Its report is expected sometime this spring.

MacKay, beginning his third term, is also co-chair in the House of the Congressional Caucus on Competitiveness. That group is one of many in Washington concerned about the nation's continued ability to compete with the rest of the industrial world.

"Many people see achieving a better ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies